Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 9Recruiting 2Active not recruiting 1

Sponsor Class

NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Breast Neoplasms 24Carcinoma, Intraductal, Noninfiltrating 3Breast Cancer Female 2Premenopausal Breast Cancer 1Polycystic Ovary Syndrome 1Ovarian Neoplasms 1Neoplasms 1Neoplasm Recurrence, Local 1Infertility 1Hot Flashes 1Carcinoma, Lobular 1Breast Neoplasms, Male 1Breast Carcinoma In Situ 1Breast Cancer Subjects 1Anovulation 1

Interventions

Paclitaxel 2Doxorubicin 2Cyclophosphamide 2pegfilgrastim 1exemestane 1Trastuzumab 1Taxes 1Tamoxifen 1Psychiatric Rehabilitation 1Mental Status and Dementia Tests 1Leuprolide 1Letrozole 1Immunotherapy 1Goserelin 1Everolimus 1Docetaxel 1Carboplatin 1Anastrozole 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Active not recruiting × Breast Neoplasms, Male × Tamoxifen × Clear all
NCT01674140 2026-02-10

e3

SWOG Cancer Research Network

Phase 3 Active not recruiting
1,939 enrolled 15 charts
Breast

Breast Neoplasms, Breast Neoplasms, Male

Data powered by HemOnc (CC BY 4.0) Colophon âš¡